Computer-Assisted HIV Prevention for Young Drug Users

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by National Development and Research Institutes, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Daytop (adolescent treament program)
St. Luke's-Roosevelt Hospital Center
Information provided by:
National Development and Research Institutes, Inc.
ClinicalTrials.gov Identifier:
NCT00182585
First received: September 10, 2005
Last updated: August 11, 2008
Last verified: August 2008
  Purpose

In this study, the investigators are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies.


Condition Intervention
HIV
Procedure: computer-based HIV, STD & Hepatitis Education
Procedure: educator-delivered HIV, STD and Hepatitis education

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Computer-Assisted HIV Prevention for Young Drug Users

Resource links provided by NLM:


Further study details as provided by National Development and Research Institutes, Inc.:

Primary Outcome Measures:
  • HIV risk behavior

Secondary Outcome Measures:
  • knowledge related to HIV, Hepatitis, STDs
  • behavioral intentions
  • attitudes toward risk-reduction behavior
  • feedback on intervention

Estimated Enrollment: 56
Study Start Date: August 2004
Detailed Description:

Adolescents and young adults who use drugs are at high risk for infection with HIV, STDs and other diseases with similar transmission dynamics. Although several age-appropriate and effective HIV, STD and disease prevention efforts have been identified for young substance abusers, most interventions have been narrow in focus and are generally not structured to readily address changing patterns of drug use among adolescents that place them at risk for infection with these diseases. In this study, we are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies. We plan to develop this program with the input from the target population of adolescents and young adults. We also plan to conduct a randomized, controlled trial to evaluate the benefit of including this program in HIV and disease prevention efforts with youth in substance abuse treatment. In so doing, we will evaluate the ability of the program to promote accurate knowledge about HIV and other diseases, promote self-efficacy to reduce risk behavior and change actual rates of risk behavior among young substance abusers. This computer-based program will be designed to promote the increased adoption of effective HIV and disease prevention science for this population. New information about changing patterns of drug use and HIV risk behaviors can be readily incorporated into the program as it becomes available. The program can be easily exported and able to be applied with fidelity. Importantly, the program will be structured such that a therapist or educator may customize the program content for use by various sub-populations of substance-abusing adolescents and young adults. Thus, the program will be able to address risk factors specific to each young drug user. This program may address many of the challenges associated with the current delivery of evidence-based HIV prevention programs to this population.

  Eligibility

Ages Eligible for Study:   13 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Aadolescents in outpatients substance abuse treatment
  • Ages 13 - 18 years
  • Within first month of treatment entry

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00182585

Locations
United States, New York
Daytop
Brooklyn, New York, United States, 11217
St. Luke's-Hospital, CAPA Program
New York, New York, United States, 10025
Sponsors and Collaborators
National Development and Research Institutes, Inc.
Daytop (adolescent treament program)
St. Luke's-Roosevelt Hospital Center
Investigators
Principal Investigator: Lisa Marsch, PhD National Development and Research Institutes, Inc.
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00182585     History of Changes
Other Study ID Numbers: R01 DA015964
Study First Received: September 10, 2005
Last Updated: August 11, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by National Development and Research Institutes, Inc.:
HIV
hepatitis
STDs
adolescents
addiction
treatment
prevention
HIV and related risk behavior among youth in drug treatment

ClinicalTrials.gov processed this record on July 28, 2014